[ad_1]
© Reuters. Regeneron Pharma Earnings, Income Beat in Q3Investing.com – Regeneron Pharma (NASDAQ:) reported on Thursday third quarter that beat analysts’ forecasts and income that topped expectations.
Regeneron Pharma introduced earnings per share of $15.37 on income of $3.45B. Analysts polled by Investing.com anticipated EPS of $10.17 on income of $2.72B.
Regeneron Pharma shares are down 3% from the start of the yr, nonetheless down 5.03% from its 52 week excessive of $686.62 set on September 3. They’re under-performing the S&P 500 which is up 24.08% from the beginning of the yr.
Regeneron Pharma follows different main Healthcare sector earnings this month
Regeneron Pharma’s report follows an earnings beat by J&J on October 19, who reported EPS of $2.6 on income of $23.34B, in comparison with forecasts EPS of $2.35 on income of $23.64B.
Thermo Fisher Scientific had beat expectations on October 27 with third quarter EPS of $5.76 on income of $9.33B, in comparison with forecast for EPS of $4.68 on income of $8.38B.
Keep up-to-date on the entire upcoming earnings studies by visiting Investing.com’s earnings calendar
Fusion Media or anybody concerned with Fusion Media is not going to settle for any legal responsibility for loss or harm because of reliance on the knowledge together with information, quotes, charts and purchase/promote indicators contained inside this web site. Please be totally knowledgeable relating to the dangers and prices related to buying and selling the monetary markets, it is likely one of the riskiest funding varieties attainable.
[ad_2]
Source link
